TSTatiana Borba Spader

Tatiana Borba Spader

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Tatiana Borba Spader has a total of 8 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • In Vitro Interactions of Amphotericin B Combined with Non-antifungal Agents Against Rhodotorula mucilaginosa Strains

    by Tatiana Borba Spader, Mauricio Ramírez-Castrillón, Patricia Valente, Sydney Hartz Alves, Luiz Carlos Severo

    Rhodotorula species are emerging as opportunistic pathogens, causing catheter-associated fungemia in patients with compromised immunity. R. mucilaginosa is considered the most common species involved in human infections. Correct identification and susceptibility testing of Rhodotorula isolates recovered from the blood stream or central nervous system are essential to determine the best management of this unusual infection. The antifungal susceptibility tests showed that Rhodotorula was susceptible to low concentrations of amphotericin B (AMB) but was less susceptible to voriconazole. Combinations of AMB plus several non-antifungal medications were evaluated against 35 susceptible (Rm AMB-S) and resistant (Rm AMB-R) clinical Rhodotorula isolates using the broth microdilution checkerboard technique. We showed that in vitro exposure to increasing concentrations of AMB changed the susceptibility profile to these strains, which were named the Rm AMB-R group. The most synergistic interactions were AMB + simvastatin, followed by AMB + amlodipine and AMB + warfarin. Synergism and antagonism were observed in both groups for the combination AMB + cyclosporine A. AMB combined with a fluoroquinolone (AMB + levofloxacin) also demonstrated antagonism for the Rm AMB-S strains, but a high percentage of synergistic interactions was observed for the Rm AMB-R group. A combination drug approach can provide a different strategy to treat infections caused by AMB-resistant R. mucilaginosa.


  • Open Access

    Infecções causadas por malassezia: novas abordagens

    by Mariane De Mello Maraschin, Tatiana Borba Spader, Débora Alves Nunes Mario, Luana Rossato Siqueira Motta, Paulo Guilherme Markus Lopes

    O gênero Malassezia compreende fungos leveduriformes lipofílicos e lipodependentes que recentemente sofreram mudanças em sua classificação taxonômica, com a introdução de quatro novas espécies: M. globosa, M. obtusa, M. slooffiae e M. restricta, além das espécies M. furfur, M. pachydermatis e M. sympodialis, anteriormente descritas. Estes fungos estão associados a vários quadros patológicos que incluem infecções como a pitiríase versicolor, dermatite seborréica, dermatite atópica, fungemia, entre outros. Estes quadros eram, até pouco tempo atrás, considerados exclusivamente causados pela espécie M. furfur. As mudanças na classificação taxonômica do gênero Malassezia levaram a uma reavaliação dos procedimentos laboratoriais utilizados para a identificação deste agente etiológico. Entre eles podemos citar o estudo e a caracterização morfológica das espécies, sua tolerância térmica, suas necessidades nutricionais para determinados tipos de ácidos graxos, bem como a composição e as características do DNA de cada uma delas.